COMMUNIQUÉS West-GlobeNewswire

Envudeucitinib Long-term Data Positioned to Set a New Standard for Plaque Psoriasis Treatment, Delivering Highest Reported PASI 100 Skin Clearance Among Oral Therapies
10/08/2026
– ONWARD3 data show 54% of patients reached complete skin clearance (PASI 100) after 48 weeks of continuous envudeucitinib treatment – – Favorable long - term safety and tolerability profile remained consistent with [...]
Bionano Reports Second Quarter 2026 Results and Provides a Business Update
10/08/2026
Conference call today, August 10, 2026, at 4:30 PM ET SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2026. "Our [...]
Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance
10/08/2026
FREMONT, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today reported financial results for [...]
TELA Bio Reports Second Quarter 2026 Financial Results
10/08/2026
MALVERN, Pa., Aug. 10, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial [...]
Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures
10/08/2026
Expanded collaboration applies multiplex protein profiling across 86,000 additional samples, enabling researchers to move beyond single biomarkers toward a precision-medicine understanding of disease heterogeneity, [...]
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
10/08/2026
Completed acquisition of Ouro Medicines with Gilead Sciences to advance potential first and best-in-class T-cell engager Forecast at least €1.6B of cash remaining after funding portfolio to first gamgertamig approval [...]
Women's Health Collective Canada and GreenShield Launch Partnership to Advance Midlife Women's Health Research and Support
10/08/2026
National partnership will help generate critical evidence and improve awareness, education, and support for women navigating the menopause transition and beyond in Canada TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Women [...]
L’Association canadienne pour l’équité en santé des femmes et GreenShield lancent un partenariat en faveur de la recherche et du soutien dans le domaine de la santé des femmes dans la cinquantaine
10/08/2026
Ce partenariat national aidera à produire des données probantes et à améliorer les ressources de sensibilisation, d’éducation et de soutien pour les femmes vivant la transition vers la ménopause au Canada TORONTO, 10 [...]
Compass Health to purchase Friday Harbor facility from San Juan County, supporting behavioral health care in the islands long-term
10/08/2026
State funding and a decades-long county partnership secure the building's future FRIDAY HARBOR, Wash., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Compass Health is purchasing its Friday Harbor facility located at 520 Spring [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2026
10/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 04th August to 05th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 32 - 2026
10/08/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 4 août au 5 août 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston
10/08/2026
CEO Michael Halstead to participate in a fireside chat on Wednesday, August 12 at 12:00 p.m. EDT NEW YORK and TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “ [...]
Metabio Advances Global Preventive Healthcare with Integrated AI-Powered Bioresonance Ecosystem
10/08/2026
HONG KONG, Aug. 10, 2026 (GLOBE NEWSWIRE) -- As global healthcare priorities increasingly shift from reactive treatment to proactive wellness management, health technology enterprise Metabio today announced the [...]
NTG Nordic Transport Group publishes interim report for H1 2026
10/08/2026
Company announcement no. 29 – 26 10 August 2026 NTG Nordic Transport Group publishes interim report for H1 2026 The interim report for H1 2026 is enclosed. In connection with publication of the results for H1 2026, a [...]
Zealand Pharma - Transactions related to share buy-back program (week 32, 2026)
10/08/2026
Company announcement No. 37 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 32, 2026) Copenhagen, Denmark, August 10, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
New research explores how data can help detect disease earlier and improve patient care
10/08/2026
VANCOUVER, British Columbia, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Every patient has a story, yet no single source of health information tells the whole story. What if researchers could use data to identify multiple [...]
NeOnc Heads into a High-Stakes Week as Highly Anticipated NEO100 Phase 2a Data Readout Nears
10/08/2026
Topline Results from Intranasal NEO100 in Recurrent IDH1-mutant High-grade Glioma could mark a Major Clinical Catalyst for NeOnc DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) – NeOnc Technologies (NASDAQ: NTHI [...]
ITM Receives Complete Response Letter for ¹⁷⁷Lu-edotreotide (ITM-11)
10/08/2026
No clinical safety or efficacy issues identified and no additional clinical or nonclinical data requested The Complete Response Letter for the ongoing ITM-11 New Drug Application (NDA) cites Chemistry, Manufacturing and [...]
Novo Nordisk A/S - share repurchase programme
10/08/2026
Bagsværd, Denmark, 10 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]

Pages